This can lead to some large bumps in the road, as ResMed just discovered ... The Phase III study assessed the efficacy and safety of tirzepatide — a 'GLP-1' drug that causes weight loss — in treating ...
Hosted on MSN12mon
ResMed positive as Philips halts sales of sleep therapy devicesPhilips’ (NYSE:PHG) decision to halt sales of its respiratory care devices in the U.S. to meet regulatory requirements is likely favorable to its rival, ResMed ... recall of sleep apnea and ...
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results